Insider Transactions in Q2 2022 at Achieve Life Sciences, Inc. (ACHV)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2022
|
John Bencich CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,827
-13.35%
|
$12,789
$7.43 P/Share
|
|
Apr 28
2022
|
John Bencich CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+35.4%
|
-
|
|
Apr 28
2022
|
Cindy Jacobs President & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-22.37%
|
$4,263
$7.43 P/Share
|
|
Apr 28
2022
|
Cindy Jacobs President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+47.87%
|
-
|
|
Apr 28
2022
|
Richard Alistair Stewart Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,250
-14.4%
|
$15,750
$7.43 P/Share
|
|
Apr 28
2022
|
Richard Alistair Stewart Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+24.24%
|
-
|
|
Apr 28
2022
|
Jerry Wan Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-49.78%
|
$4,683
$7.43 P/Share
|
|
Apr 28
2022
|
Jerry Wan Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+48.19%
|
-
|
|
Apr 28
2022
|
Anthony Clarke CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-6.66%
|
$1,750
$7.43 P/Share
|
|
Apr 28
2022
|
Anthony Clarke CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+21.04%
|
-
|